Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191210006078/en/



Figure 1. LHON Natural History from Interim Analysis


BusinessWire_EN 
0 11.12.19
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191208005050/en/



The National Eye Hospital (CHNO) of the Quinze-Vingt

BusinessWire_EN 
0 09.12.19
Novus Therapeutics to Participate in Two Investor Conferences
Novus Therapeutics to Participate in Two Investor Conferences


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the

BusinessWire_EN 
0 29.11.19
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005574/en/



EOSedge™ (Photo: Business Wire)




EOS imaging

BusinessWire_EN 
0 29.11.19
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/



(Photo: Business Wire)




EOS imaging (Paris:EOSI)

BusinessWire_EN 
0 26.11.19
Heat Biologics: Aktie explodiert - darauf ist jetzt zu achten!
Heat Biologics: Aktie explodiert - darauf ist jetzt zu achten!

Der Aktienkurs von Heat Biologics (WKN: A2JB4Y) erlebt derzeit ein wahres Auf und Ab. Wohin die Reise letztendlich geht, entscheiden die jetzt veröffentlichten Topline-Daten zur

sharedeals 
0 20.11.19
Novus Therapeutics Reports Third Quarter 2019 Financial Results
Novus Therapeutics Reports Third Quarter 2019 Financial Results


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial

BusinessWire_EN 
0 13.11.19
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 12.11.19
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 08.11.19
Cidara Therapeutics: Biotech-Schnäppchen knallt nach Mega-Deal
Cidara Therapeutics: Biotech-Schnäppchen knallt nach Mega-Deal
Wieder einmal zeigt sich: Die fetten Deals im Biotech-Sektor werden genau dann gelandet, wenn die Stimmung nahe Tiefpunkt ist: Cidara Therapeutics (WKN: A14R2R) verlor im Laufe des letzten Jahres....
sharedeals 
0 03.09.19
Heat auf Deutschland-Tour: Mehr als Kaffeeklatsch für Bagholders?
Heat auf Deutschland-Tour: Mehr als Kaffeeklatsch für Bagholders?
Große Initiativen bei Heat Biologics (WKN: A2JB4Y): Nach dem kurzzeitigen Kursfeuerwerk mit Gewinnen von zeitweise über +50% im Zuge eines neuen Analysten-Reports Ende vergangenen Monats, will....
sharedeals 
0 08.08.19
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE AU 28/02/2018
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE AU 28/02/2018
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 15.03.18
ALPHA MOS : CHIFFRE D'AFFAIRES ANNUEL 2017
ALPHA MOS : CHIFFRE D'AFFAIRES ANNUEL 2017
En M€ - Normes IFRS Données consolidées non auditées 2017 2016 Variation Chiffre d'affaires 4,0 7,5  -46% Alpha MOS (Euronext Paris – Compartiment C – Code ISIN :....
Actusnews 
0 16.02.18
ALPHA MOS : DEMISSION D'OLIVIER SICHEL DE SON POSTE D'ADMINISTRATEUR ALPHA MOS
ALPHA MOS : DEMISSION D'OLIVIER SICHEL DE SON POSTE D'ADMINISTRATEUR ALPHA MOS
Monsieur Olivier SICHEL, administrateur indépendant au sein du Conseil d'administration d'Alpha MOS, a informé le Conseil de sa décision de mettre un terme à ses fonctions avec effet au 19....
Actusnews 
0 29.12.17
Why These Bitcoin Stocks Are Tumbling Today
Why These Bitcoin Stocks Are Tumbling Today
Shares of three stocks, Riot Blockchain (NASDAQ: RIOT), Overstock.com (NASDAQ: OSTK), and Seven Stars Cloud Group (NASDAQ: SSC), that have ridden cryptocurrency mania to explosive gains tumbled on....
TheMotleyFool 
0 22.12.17
Bitcoin Plunges 20% -- Is the Rally Over?
Bitcoin Plunges 20% -- Is the Rally Over?
It's been a tough week for cryptocurrencies in general, and bitcoin in particular. After reaching an all-time high of almost $20,000 just a week ago, bitcoin hit a low of $10,400 on Coinbase....
TheMotleyFool 
0 22.12.17
Ask a Fool: Are Any Bitcoin Stocks Worth Buying?
Ask a Fool: Are Any Bitcoin Stocks Worth Buying?
I consider bitcoin and other digital currencies to be highly speculative investments, and people shouldn't buy them with any money they can't afford to lose.Stocks of companies that could profit....
TheMotleyFool 
0 22.12.17
Why Riot Blockchain Stock Is Soaring... Again
Why Riot Blockchain Stock Is Soaring... Again
Shares of Riot Blockchain (NASDAQ: RIOT) are up 15% as of 12:00 p.m. EST after the company announced it raised a fresh round of capital by selling stock and warrants in a private placement. A....
TheMotleyFool 
0 19.12.17
Bitcoin Stocks: It's the Name That Counts
Bitcoin Stocks: It's the Name That Counts
As the tech sector boomed during the late 1990s, shrewd companies quickly figured out how to send their share prices soaring. If they renamed their company to something that ended with ".com,"....
TheMotleyFool 
0 19.12.17
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Monday was another record-setting day for major benchmarks, which had solid gains of between 0.5% and 1%. Market participants were optimistic that they'll get the corporate tax cuts that they've....
TheMotleyFool 
0 18.12.17
Why Riot Blockchain, Inc Stock Is Soaring on Monday
Why Riot Blockchain, Inc Stock Is Soaring on Monday
Shares of Riot Blockchain (NASDAQ: RIOT) are soaring, rising about 22% as of 12:30 p.m. EST. The company's soaring share price follows the launch of CME's bitcoin futures and a short-lived surge....
TheMotleyFool 
0 18.12.17
Here's Why Marinus Pharmaceuticals Is Soaring Today
Here's Why Marinus Pharmaceuticals Is Soaring Today
Welcome to the popular clique, kid. Shares of clinical-stage biopharma Marinus Pharmaceuticals (NASDAQ: MRNS) rose as much as 22.2% by noon EST after the company announced it will be added to the....
TheMotleyFool 
0 14.12.17
Why Celldex Therapeutics Stock Reversed Course in November
Why Celldex Therapeutics Stock Reversed Course in November
Shares of the struggling small-cap biotech Celldex Therapeutics (NASDAQ: CLDX) finally showed some signs of life in November. Specifically, the biotech's stock rose by a healthy 27.6% last....
TheMotleyFool 
0 10.12.17
3 Top Stocks Under $10
3 Top Stocks Under $10
There's cheap, then there's cheap. Some stocks are cheap in the sense of the definition of the word relating to relatively low price compared to their potential value. Others are cheap under....
TheMotleyFool 
0 10.12.17
ALPHA MOS : Informations relatives au nombre total de droits de vote
ALPHA MOS : Informations relatives au nombre total de droits de vote
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 06.12.17